HPLC-UV (HI, hydrophobic interaction)

Determination of identity, purity and related impurities

Therapeutic Modalities:

Biologics, Cell & Gene Therapies

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Pharmacopoeia:

EP 2.2.29, USP <621>